Thalamic projections to parietal regions of cerebral cortex were investigated in the cat by retrograde degeneration and retrograde transport techniques. Studies of retrograde cellular changes indicate cortically projecting cells in the lateroposterior nucleus (LP), rostral pulvinar (Pul), and the ventral part of the laterodorsal nucleus (LD). When lesions were placed in the cortex of young kittens, clear chromatolytic changes and cell loss were also consistently observed in middle and caudal parts of the ventroanterior nucleus (VA). Investigations of retrograde transport following intracortical injections of horseradish peroxidase have confirmed the results of retrograde degeneration studies by demonstrating cortically projecting cells in VA, LP, LD, and Pul. Retrograde transport studies also indicate cortically projecting cells in the central lateral nucleus. Material from both experimental techniques demonstrates a loose topographic organization of the projections from the lateral thalamus. Anterior parts of LP project to the anterior lateral gyrus and anterior middle suprasylvian gyrus. Middle LP and rostral Pul project to the middle suprasylvian gyrus.

Keywords:
Cortex, Degeneration, Parietal, Thalamus
This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.